hydralazine has been researched along with pyruvic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burns, AH; Burns, LA; Jurenka, LU; Summer, WR | 1 |
Ito, Y; Iwaki, M; Ogiso, T | 1 |
Bassenge, E; Bünger, R; Schwemmer, M; Sommer, O | 1 |
3 other study(ies) available for hydralazine and pyruvic acid
Article | Year |
---|---|
Myocardial metabolic effects of in vivo hydralazine treatment of streptozotocin-diabetic rats.
Topics: Animals; Cholesterol; Diabetes Mellitus, Experimental; Dichloroacetic Acid; Female; Glucose; Heart; Hydralazine; Male; Myocardium; Oxidation-Reduction; Oxygen Consumption; Pyruvates; Pyruvic Acid; Rats; Rats, Inbred Strains; Triglycerides | 1991 |
In vitro kinetic studies of the reaction of hydralazine and its acetone hydrazone with pyruvic acid.
Topics: Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Drug Stability; Hydralazine; Hydrazones; Kinetics; Pyruvates; Pyruvic Acid | 1988 |
Antioxidant pyruvate inhibits cardiac formation of reactive oxygen species through changes in redox state.
Topics: Animals; Antioxidants; Coumaric Acids; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guinea Pigs; Hydralazine; In Vitro Techniques; Lactic Acid; Mitochondria, Heart; Multienzyme Complexes; Myocardial Ischemia; Myocardium; NADH, NADPH Oxidoreductases; Oxidation-Reduction; Pyruvic Acid; Rabbits; Reactive Oxygen Species; Xanthine Oxidase | 2000 |